Introduction
SLE is a prototypic systemic autoimmune disease characterized by the production of a variety of autoantibodies which are directed predominantly against nuclear antigens [1] . In both SLE patients and the lupus mouse models, the presence of anti-DNA antibodies, especially anti-dsDNA antibodies, is closely correlated with clinical disease and hence of diagnostic and even prognostic value [2] . Purified native mammalian DNA is however a weak immunogen [3, 4] . It is not clear whether these anti-DNA responses are induced against somatic DNA, or represent cross-reactivity of the antibodies to pathogens -'molecular mimicry' [5] , or an 'anti-idiotypic response' [6] . A recent model proposes that some uncommon modifications or handling of self-tissue components, including nucleic acids, may explain such altered auto-antigenicity, and that the modified self-antigens are most likely to originate from dying cells [7] [8] [9] [10] . The macrophage-mediated mechanism for removal of dying cells is defective in some autoimmune diseases including SLE [11] . As a consequence, dying cells (e.g. following infection or even due to normal tissue/cell turnover) accumulate and the cellular contents normally-shielded from the adaptive immune system may be released acting as the "auto-antigens". A key question is still however "what is the process that renders DNA 'immunogenic'?".
DCs are potent antigen presenting cells (APC) playing a key role in the initiation of immune responses, and they may take up dying cells for antigen processing and presentation [12] . We report here that DCs loaded with necrotic cells (DC/nec) but not apoptotic cells (DC/apo) are powerful inducers of anti-DNA antibody response.
Injection of syngeneic DC/nec not only accelerated disease progression in the MRL/MpJ-lpr/lpr (MRL/lpr) lupus-prone mice but also induced a lupus-like disease in the MRL/MpJ-+/+ (MRL/+) wild-type control strain. However, despite the fact that high levels of anti-dsDNA antibodies were also detected in the DC/nec-treated C57BL/6 mice, these animals failed to develop clinical disease. We show further evidence indicating that the isotype of anti-dsDNA antibodies are also critical. The DC-induced pathological changes in susceptible mouse strains correlate closely with the ability of these cells to mediate a Th1 type of response. This includes the release of high levels of IFN-γ and reduced level of IL-10 in vitro and, more importantly, the preferential induction of pathogenic IgG2a anti-dsDNA autoantibodies that readily form renal immune complex deposits in vivo.
Results

Anti-DNA antibody responses.
To test the hypothesis that anti-DNA responses can be induced by DCs that had captured nuclear antigens in the form of dying cells leading to lupus disease, we generated DCs from mouse bone marrow. The cells were then allowed to phagocytose either necrotic or apoptotic splenocytes in vitro, before being injected intravenously into syngeneic young mice (see Methods). Three strains of mice were tested: the MRL/lpr strain which carries a defective Fas gene and develops a spontaneous lupuslike disease as they age [13, 14] , the wild-type MRL/+ strain that express intact Fas, and a normal inbred C57BL/6 strain. After injection of the DCs pre-loaded with necrotic cells into young mice at 5-weeks of age, highly though transiently elevated serum anti-dsDNA was detected in the MRL/lpr, but not the MRL/+ (<30U/ml), strain (Data not shown). However, when DC/nec were injected into adult mice (11 weeks of age), strong and rapid anti-dsDNA responses were detected not only early in 7 shows results from a separate experiment in which female MRL/+ mice that had received 2 (instead of 3) injections of DC/nec also developed such typical facial lesions, thought at much a later stage (Fig. 2c, 11 -months post injection). In a total of 10 DC/nec-treated female MRL/+ mice from 3 separate experiments (n = 3, 3, 4; treatment started at the age of 11-week), 9 developed such lesions including 5 of them extensively (results from Exps. I and II are shown in Fig. 2 ). In contrast, no such lesion was observed in mice treated with DC/apo, DC, or PBS-treated control group (Fig. 2a, 2c ), or in necrotic cells alone (Nec) or apoptotic cells alone (Apo) treated groups (data not shown). Neither male MRL/+ mice (Fig. 2b, M ) nor C57BL/6 mice of either sex that received DC/nec or DC/apo developed the rash. Some localised facial lesions were also seen early on in the DC/nec-treated MRL/lpr mice similar to those observed in the IL-18-treated MRL/lpr mice reported by us previously [16] .
However, the lesions were less extensive than those observed in the DC/nec-treated MRL/+ mice, probably because the MRL/lpr mice died soon after the treatment, before the lesions could fully develop.
Histological examination of the affected skin showed a focal lymphohistiocytic infiltrate in the interstitium of the papillary dermis and around the bulbs of hair follicles ( Fig. 2d [ii] , [iii] ). Detailed examination of the alopecic skin revealed a significant increase in the number of catagen, and decrease in anagen, hair follicles, as evidenced by scattered apoptotic bodies in the outer root sheath, disappearance of the inner root sheath and progressive thickening, hyalinization and corrugation of the vitreous membrane (Fig. 2d[v] , and histograms). Anagen and catagen are two types of hair follicles at different phases of hair cycling. In normal skin, majority of hair follicles are anagens (~90%) which are in the phase of active hair production, while catagens are in the involutionary stage of the hair cycle characterized by the loss of mitotic activity being short lasting and development of apoptotic cell death in the outer root sheath [17, 18] . The present findings indicate that a process of catagenization within the skin with mild peri-bulbar follicular inflammation can be induced following such abrupt but transient insults of DC/nec injection. The DC/necinduced histopathology, although not exactly the same as the typical chronic lupus dermatitis in human disease, is more in keeping with a non-scaring alopecia such as the allied autoimmune skin disease of alopecia areata also observed clinically in lupus patients [17, 18] .
Proteinuria and renal histopathology.
Glomerulonephritis, the renal involvement caused by immune complex deposition and complement activation, is a severe complication of lupus disease and represents the major cause of death [19] . We next assessed the renal pathological changes in the DCtreated mice. MRL/lpr lupus mice develop age-dependent spontaneous and progressive proteinuria, which is not seen in untreated MRL/+ or C57BL/6 mice up to 7 months of age (Fig. 3a, right panel) . Following injection of DCs, however, high levels of proteinuria were observed in the DC/nec-treated MRL/+ mice (Fig. 3a, left panel), at levels similar to those seen in aged MRL/lpr mice (5-6 months, female, right panel) with overt clinical disease, but not in the similarly treated C57BL/6 mice.
In contrast, significantly lower levels of proteinuria were detected in MRL/+ mice treated with DC/apo, DCs alone (DC), apoptotic (Apo) or necrotic (Nec) cells alone.
Acceleration in proteinuria development was also observed in MRL/lpr mice following injection of DC/nec. However, unlike the MRL/+ mice which gradually recovered after cessation of treatment, the MRL/lpr strain developed progressively severe proteinuria and died early. Light microscopy showed cellular proliferation in the glomeruli (glomerular hypercellularity) of female MRL/+ mice treated with DC/nec but not with DC/apo (data not shown). Immunostaining for IgG revealed substantial immune complex (IC) deposition in kidneys of the DC/nec-treated, but not the DC/apo-treated, female MRL/+ mice (Fig. 3b) . Such deposits were found mainly within the affected glomeruli, some were focalised around the hilar region (Fig. 3b[i] ) while others were more diffusely distributed (Fig. 3b[ii] ). This was further confirmed by electron microscopy showing large electron dense deposits in the mesangial areas, with expansion of the mesangium (Fig. 3c, arrows) . The DC/nec-induced renal pathology and proteinuria were generally more prominent and appeared earlier in female than male MRL/+ mice, but such gender differences were less clear cut for the MRL/lpr strain. No lymph node enlargement or splenomegaly was found in treated or untreated MRL/+ and C57BL/6 mice. No gross pathology was detected in the joints, lungs, heart and liver of these mice.
Anti-dsDNA antibody isotype and DC cytokine expression profile.
The lupus-like disease induced in the wild type control MRL/+ strain following treatment with DC/nec can be first explained by the strong anti-dsDNA responses, which reached levels similar to those seen in terminally ill MRL/lpr lupus mice (Fig.   1 histograms) . However, the failure to induce clinical disease (skin lesions, proteinuria and renal pathology) in C57BL/6 mice by DC/nec or DC/apo, despite the presence of considerable levels of anti-DNA antibodies ( Fig. 1 upper right (Fig. 4b ) or absence (data not shown) of LPS. Kinetic study indicated that the differences in IFN-γ level did not correlate with differences in IL-12 activity, and the early phase of IFN-γ release by MRL/+ DC/nec in particular was independent of IL-12 activity (Fig. 4b) . Fig. 4b also shows that IL-12 p70 production by DC/nec and DC/apo from both MRL/+ and C57/BL6 strains of mice is significantly suppressed instead when compared to that of DCs alone (DC). In addition, the production of IFN-γ did not correlate with IL-12/IL-23 (p40) and IL-18 activities either, and only low levels of IL-4 and IL-5 were detected in the DC cultures tested (data not shown).
We next studied the in vivo relevance of the above findings. Isotypic analysis of the serum anti-dsDNA antibodies revealed that certain isotypes of these autoantibodies were differentially induced in the mouse strains following treatment with DC/nec, DC/apo or DC. As shown in Fig. 5a , anti-dsDNA antibodies of the IgG1 isotype were readily detectable in the treated mice of both MRL/+ and C57BL/6 strains, as well as the IgM and IgG2b isotypes in the treated C57BL/6 mice. However, the levels of these antibodies were generally comparable among the three differently treated groups of either strain. In contrast, in the MRL/+ mice, serum levels IgG2a anti-dsDNA antibody levels were significantly higher in the DC/nec-treated mice ( We then also carried out detailed assessments of the renal ICs using IgG1 and IgG2a isotype-specific antibodies. This revealed that ICs containing IgG1 and IgG2a were both present in the kidneys of DC/nec-treated MRL/+ mice. There was no significant difference in the frequency of IgG1 ICs between the mice treated with DC/nec and with DC/apo. However, kidney sections from the DC/nec-treated female MRL/+ disease mice exhibited strong IgG2a positive glomerular deposits with a frequency significantly higher than those from mice treated with DC/apo or untreated control mice (Fig. 5b, histograms) . More importantly, whereas the IgG1 ICs were generally weaker and more diffusely distributed, the IgG2a ICs were much stronger and focalised around glomerular hilar regions ( Fig. 5b photograph, in red), a pattern similar to that seen in aged MRL/lpr mice. By comparison, minimal IC deposits for both IgG1 and IgG2a were detected in the DC/nec and DC/apo-treated C57BL/6 mice. Similar results were obtained by using the isotypic (IgG2a) specific polyclonal ( The uptake of necrotic cells that provides both the nuclear antigens and the endogenous signals for DC maturation may account for their ability to induce anti-DNA antibody response in vivo. We also show here that MRL DCs after being primed by necrotic cells are hypersensitive to LPS stimulation to produce high levels of IFN-γ in vitro. IFN-γ is a Th1 cytokine known to be crucial for IgG2 antibody isotype switching in mouse. Therefore, both endogenous and exogenous signals appear to be required for the DCs to mediate such a Th1 type response, and this may explain the ability of these cells to induce preferentially IgG2a anti-dsDNA antibodies in vivo.
However, the direct in vivo relevance of LPS to the present experimental model is still yet to be established, which may be associated with the role of environmental pathogens. All the animals on experimental schedule in the present study shown were housed in conventional animal facility, and it will be interesting to compare them with those kept under specific pathogen free or even germ-free condition in future studies.
IgG2 anti-DNA antibodies are thought to be more pathogenic than other subclasses for many of their immunophysiological features [13, [32] [33] [34] . A switch from IgM to IgG2a and IgG2b subclasses has been previously shown to herald the onset of severe disease in the NZB/W lupus-prone mouse model [35] and, more recently, these IgG2 anti-dsDNA antibodies were found to be more frequently present in lupus patients with renal disease [36] . The lack of clinical manifestations in the DC/nec-treated C57BL/6 mice despite significant serum anti-dsDNA total IgG (Fig. 1 ) levels, which is also in agreement with a recent report [37] , may therefore be explained by differences in the quality of the antibody responses induced (Fig. 5) . The unique induction of IgG2a anti-dsDNA response exclusively in the DC/nec-treated mouse group of the MRL/+ but not C57BL/6 strain (Fig. 5a) , which is consistent with the very antibody isotype associated with the immune complex deposits readily detectable in the affected kidneys (Fig. 5b) In a normal immune system, the expression of the pro-inflammatory cytokines is under tightly controlled regulatory mechanisms. IL-10 is a potent immunosuppressive cytokine controlling Th1 responses. Elevated serum IL-10 levels have been associated with lupus disease activity [42] . This may reflect a desperate yet failed attempt of the immune system to down-regulate the autoimmune responses. We show here that, in response to LPS stimulation, DC/nec from C57BL/6 mice produce much elevated levels of IL-10. The differences between MRL/+ and C57BL/+ strains of mice in the levels of IL-10 activity induced (Fig. 4) suggest that such feedback regulatory mechanism may be lacking in the MRL mice. Taken together, these findings suggest The genetic basis of SLE is complex, involving contributions from multiple genes [43] . The MRL/lpr mouse strain is a widely used classical animal model for human SLE. Lpr, identified as a mutation in Fas (CD95), interferes with T cell maturation and normal cell renewal process, allowing the release of auto-reactive T cells into the periphery and possibly the generation of 'bad' cell death [10] . Homozygosity for lpr results in a severe lupus-like disease in these mice [14] . However, other lpr congenic strains of mice that possess the lpr mutation develop lymphoproliferation but not always the lupus disease, depending on their genetic background [44] . At least two additional susceptibility loci in the MRL background have been mapped which are associated with nephritis [45] . We show here that anti-DNA responses followed by a lupus-like disease can be induced in the susceptible MRL/+ mouse strain independent of the Fas defect, and without the associated lymphoproliferation. Our present findings are based on the murine models and how these may be translated into the human disease is an important issue remains to be addressed. Our observations also suggest that while it is possible to induce autoimmunity by "DC vaccination" in susceptible individuals, this is insufficient to sustain a chronic disease and that in the absence of continuous "antigen stimulation" disease progression eventually subsides. DC purity and functional phenotypes were assessed by flow cytometry using antibodies to DC surface markers (MHC class II, CD11c, CD80, CD86 and CD40), and by their cytokine expression profiles (see below). To quantify DNA contents of the dying cells after overnight culture at 37 0 C, the apoptotic and necrotic cells were sampled, lysed and the total DNA purified using a commercial DNA purification kit (QIAamp, QIAGEN, Valencia, USA) before the DNA concentrations were measured at 260nm on a UV spectrophotometer.
Materials and Methods
Mice
Cell adoptive transfer
One million DCs loaded with either necrotic or apoptotic cells, or DCs alone; or 5 million apoptotic or necrotic cells alone, were injected in PBS intravenously into each mouse. Three or two injections were given at 14 days intervals starting at the age of 4 to 5-weeks (young) or of 11-weeks (adult).
Detection of anti-DNA responses
The mice were bled every two weeks by retro-orbital puncture under halothane anesthesia and serial dilutions of the sera tested for anti-DNA antibodies using standard ELISA protocols [46] 
Cytokine measurements
Cytokine production by DCs in vitro with or without dying cell treatment (as described above), both spontaneously or in response to LPS stimulation (5µg per ml added 4 hours after co-culture with dying cells), was determined by using commercial 
Clinical and pathological assessments
Proteinuria and hematuria were assessed using a commercially available kit (Multistix, Statistics: Student's T test was used throughout for statistical analysis, and considered p value < 0.05 (*) being significant and < 0.01 (**) highly significant. 
